Schizophrenia: Its etiology and impact

Pharmacotherapy

Volumn 16, Issue 1 II, 1996, Pages

  Miller, Del D ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2 RECEPTOR;

CELL MIGRATION; CLINICAL FEATURE; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENETIC DISORDER; HOSPITAL COST; HOSPITALIZATION; HUMAN; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

ANTIPSYCHOTIC AGENTS; COST OF ILLNESS; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030066586     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Kraepelin E. Dementia praecox and paraphrema. Barclay RM, trans. Edinburgh: ES Livingston, 1919.
2. Bleuler E. Dementia praecox; or, the group of schizophrenias. Zinkin J, trans New York. International Universities Press, 1950. (Originally published 1911 )
3. Schneider K. Clinical psychopathology New York: Grune & Stratton, 1959.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, 1994.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed Washington, DC, 1990.
6. Jablensky A. The epidemiology of schizophrenia. Curr Opin Psychiatry 1993,6.43-52.
7. Tienari P. Interaction between genetic vulnerability and family environment: the Finnish adoptive family study of schizophrenia. Acta Psychiatr Scand 1991;84:460-5.
8. Sham P, O'Callaghan E, Takei N, et al. Schizophrenia following prenatal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry 1992,160:461-6.
9. Kendell R, Adams W. Unexplained fluctuations in the risk for schizophrenia by month and year of birth Br J Psychiatry 1991;158:758-63
10. Andreasen N, Rezai K, Alliger R, et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon computed tomography and the Tower of London. Arch Gen Psychiatry 1992,49:943-58.
11. Weinberger D, Berman K, Illowsky B. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Ill A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 1988,45:609-15
12. Rice D, Miller L. The economic burden of schizophrenia. Presented at the 6th biennial research conference on the Economics of Mental Health, Bethesda, MD, September 21-22. 1992
13. Rupp A, Keith S. The costs of schizophrenia Psychiatr Clin North Am 1993,16 413-23.